{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:47:49Z","timestamp":1780087669633,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.urolonc.2012.04.014","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T13:48:10Z","timestamp":1341323290000},"page":"1643-1649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Kwang Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalsan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.04.014_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","article-title":"Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance","volume":"29","author":"Az\u00e9mar","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib2","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2012.04.014_bib3","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/01.ju.0000144505.40915.98","article-title":"Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma","volume":"172","author":"Mullerad","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","article-title":"Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology","volume":"96","author":"Raman","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.04.014_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper urinary tract cancer: Location is correlated with prognosis","volume":"48","author":"van der Poel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","article-title":"Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract","volume":"65","author":"Matsui","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.04.014_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","article-title":"Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location","volume":"98","author":"Zigeuner","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.04.014_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000471683","article-title":"Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract","volume":"20","author":"Sakamoto","year":"1991","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1464-410X.1991.tb15064.x","article-title":"Transitional cell carcinoma of the upper urinary tract: Prognostic variables and post-operative recurrences","volume":"67","author":"Krogh","year":"1991","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1464-410X.2009.08836.x","article-title":"Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy","volume":"105","author":"Abe","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2012.04.014_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.urology.2006.09.065","article-title":"Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma","volume":"69","author":"Raman","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.04.014_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib13","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting non-muscle-invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib14","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumours of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2012.04.014_bib15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199203123261108","article-title":"Bladder cancer\u2014field vs. clonal origin","volume":"326","author":"Harris","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.04.014_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1349-7006.2006.00264.x","article-title":"Development and progression of urothelial carcinoma","volume":"97","author":"Kakizoe","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2012.04.014_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199203123261104","article-title":"Clonal origin bladder cancer","volume":"326","author":"Sidransky","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2012.04.014_bib19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","article-title":"Metachronous multifocal development of urothelial cancers by intraluminal seeding","volume":"342","author":"Habuchi","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2012.04.014_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.10544","article-title":"Clonality of multifocal urothelial carcinomas: 10 Years of molecular genetic studies","volume":"101","author":"Hafner","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.04.014_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.ju.0000129541.23460.48","article-title":"Multifocal transitional cell carcinoma of the bladder and upper urinary tract: Molecular screening of clonal origin by characterizing CD44 alternative splicing patterns","volume":"172","author":"Miyake","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: A prospective, multicenter, randomized clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial)","volume":"60","author":"O'Brien","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jso.20459","article-title":"Bladder recurrence of upper urinary tract cancer after laparoscopic surgery","volume":"93","author":"Kume","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000050969","article-title":"Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract","volume":"67","author":"Koga","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2012.04.014_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.juro.2009.05.040","article-title":"The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival","volume":"182","author":"Park","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.04.014_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jnci\/85.1.53","article-title":"Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression","volume":"85","author":"Sarkis","year":"1993","journal-title":"J Natl Cancer Inst"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391200155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391200155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:03:17Z","timestamp":1761040997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391200155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S107814391200155X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.04.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}